ArticleScientific reports2020

Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells.

Abderrahim El Guerrab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.